{"AllianceGenome": "4093", "HGNC": "4093", "MIM": "138275", "_id": "2572", "_version": 1, "accession": {"genomic": ["AL162503.12", "AY340073.1", "CH471072.2", "CP068268.2", "NC_000010.11", "NC_060934.1"], "protein": ["AAA58491.1", "AAA62367.1", "AAH29517.1", "AAI26328.1", "AAI26330.1", "AAP88040.1", "BAC86947.1", "CAB62572.1", "EAW86101.1", "EAW86102.1", "EAW86103.1", "EAW86104.1", "NP_000809.1", "NP_001127838.1", "Q05329.1", "WBY73528.1"], "rna": ["AJ251501.1", "AK127375.1", "BC029517.1", "BC039038.1", "BC047899.1", "BC126327.1", "BC126329.1", "BI438818.1", "BP392604.1", "M74826.1", "M81882.1", "NM_000818.3", "NM_001134366.2", "OP680451.1", "X69936.1"], "translation": [{"protein": "NP_000809.1", "rna": "NM_000818.3"}, {"protein": "AAH29517.1", "rna": "BC029517.1"}, {"protein": "AAI26328.1", "rna": "BC126327.1"}, {"protein": "BAC86947.1", "rna": "AK127375.1"}, {"protein": "CAB62572.1", "rna": "AJ251501.1"}, {"protein": "AAA58491.1", "rna": "M74826.1"}, {"protein": "NP_001127838.1", "rna": "NM_001134366.2"}, {"protein": "AAI26330.1", "rna": "BC126329.1"}, {"protein": "AAA62367.1", "rna": "M81882.1"}, {"protein": "WBY73528.1", "rna": "OP680451.1"}]}, "alias": "GAD65", "ec": "4.1.1.15", "ensembl": {"gene": "ENSG00000136750", "protein": ["ENSP00000259271", "ENSP00000365437", "ENSP00000390434", "ENSP00000498009"], "transcript": ["ENST00000259271", "ENST00000376248", "ENST00000376261", "ENST00000428517", "ENST00000648567"], "translation": [{"protein": "ENSP00000365437", "rna": "ENST00000376261"}, {"protein": "ENSP00000259271", "rna": "ENST00000259271"}, {"protein": "ENSP00000390434", "rna": "ENST00000428517"}, {"protein": "ENSP00000498009", "rna": "ENST00000648567"}], "type_of_gene": "protein_coding"}, "entrezgene": "2572", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 24.7439896415, "exp_mis": 211.303655838, "exp_syn": 105.379038807, "lof_z": 4.13092300867447, "mis_z": 1.52439169274044, "mu_lof": 1.67566481766e-06, "mu_mis": 1.87925141943e-05, "mu_syn": 9.14083378717e-06, "n_lof": 4.0, "n_mis": 166.0, "n_syn": 89.0, "p_li": 0.898626707693029, "p_null": 1.58857836027205e-06, "p_rec": 0.101371703728611, "syn_z": 0.989144661064555}, "bp": 1758, "cds_end": 26589890, "cds_start": 26505738, "n_exons": 16, "nonpsych": {"exp_lof": 22.0763853446, "exp_mis": 190.930890948, "exp_syn": 95.0588903992, "lof_z": 3.98734730296697, "mis_z": 1.42107832097631, "mu_lof": 1.67566481766e-06, "mu_mis": 1.87925141943e-05, "mu_syn": 9.14083378717e-06, "n_lof": 3.0, "n_mis": 152.0, "n_syn": 85.0, "p_li": 0.951160347230113, "p_null": 1.48978177508639e-06, "p_rec": 0.0488381629881121, "syn_z": 0.649556830459953}, "nontcga": {"exp_lof": 22.733346507, "exp_mis": 194.368252132, "exp_syn": 96.917599485, "lof_z": 4.08272658347181, "mis_z": 1.44257071233056, "mu_lof": 1.67566481766e-06, "mu_mis": 1.87925141943e-05, "mu_syn": 9.14083378717e-06, "n_lof": 3.0, "n_mis": 154.0, "n_syn": 79.0, "p_li": 0.957707011859586, "p_null": 8.5027657606001e-07, "p_rec": 0.0422921378638376, "syn_z": 1.15239358480808}, "transcript": "ENST00000376261.3"}, "exons": [{"cdsend": 26300961, "cdsstart": 26216809, "chr": "10", "position": [[26216306, 26216885], [26217609, 26217669], [26217841, 26217991], [26219042, 26219276], [26223886, 26223977], [26224538, 26224651], [26229661, 26229777], [26245920, 26246000], [26269118, 26269173], [26270639, 26270756], [26273635, 26273700], [26281008, 26281087], [26286344, 26286494], [26292464, 26292572], [26292901, 26292991], [26300787, 26300995], [26304033, 26304562]], "strand": 1, "transcript": "NM_000818", "txend": 26304562, "txstart": 26216306}, {"cdsend": 26300961, "cdsstart": 26216809, "chr": "10", "position": [[26216773, 26216885], [26217609, 26217669], [26217841, 26217991], [26219042, 26219276], [26223886, 26223977], [26224538, 26224651], [26229661, 26229777], [26245920, 26246000], [26269118, 26269173], [26270639, 26270756], [26273635, 26273700], [26281008, 26281087], [26286344, 26286494], [26292464, 26292572], [26292901, 26292991], [26300787, 26304558]], "strand": 1, "transcript": "NM_001134366", "txend": 26304558, "txstart": 26216773}], "exons_hg19": [{"cdsend": 26589890, "cdsstart": 26505738, "chr": "10", "position": [[26505235, 26505814], [26506538, 26506598], [26506770, 26506920], [26507971, 26508205], [26512815, 26512906], [26513467, 26513580], [26518590, 26518706], [26534849, 26534929], [26558047, 26558102], [26559568, 26559685], [26562564, 26562629], [26569937, 26570016], [26575273, 26575423], [26581393, 26581501], [26581830, 26581920], [26589716, 26589924], [26592962, 26593491]], "strand": 1, "transcript": "NM_000818", "txend": 26593491, "txstart": 26505235}, {"cdsend": 26589890, "cdsstart": 26505738, "chr": "10", "position": [[26505702, 26505814], [26506538, 26506598], [26506770, 26506920], [26507971, 26508205], [26512815, 26512906], [26513467, 26513580], [26518590, 26518706], [26534849, 26534929], [26558047, 26558102], [26559568, 26559685], [26562564, 26562629], [26569937, 26570016], [26575273, 26575423], [26581393, 26581501], [26581830, 26581920], [26589716, 26593487]], "strand": 1, "transcript": "NM_001134366", "txend": 26593487, "txstart": 26505702}], "generif": [{"pubmed": 12021098, "text": "Molecular mimicry in type 1 diabetes: immune cross-reactivity between islet autoantigen and human cytomegalovirus but not Coxsackie virus."}, {"pubmed": 12021103, "text": "The PEVKEK region of the pyridoxal phosphate binding domain of GAD65 expresses a dominant B cell epitope for type 1 diabetes sera"}, {"pubmed": 12097368, "text": "GAD65-specific B cells and the antibodies they secrete appear to modulate the autoimmune T cell repertoire by down-regulating T cell epitopes in an immunodominant area while boosting epitopes in distant or cryptic regions."}, {"pubmed": 12196483, "text": "GAD2 in type 1 diabetes.  GAD2 does not play a major role in type 1 diabetes in these two European populations."}, {"pubmed": 12197888, "text": "The effect of GAD65 on T-cell activation in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity was evaluated."}, {"pubmed": 12296864, "text": "The alpha-helical secondary structure of the GAD65 C-terminus must be denatured to generate linear epitopes. The N-terminus is both surface-exposed and linear in the native structure. Masking membrane interactions must be broken for B-cell recognition."}, {"pubmed": 12376704, "text": "GAD gene transfer into glutamatergic excitatory neurons leading to an inhibitory bias with altered network activity and a neuroprotective phenotype holds potential for treatment of Parkinson's disease"}, {"pubmed": 12503190, "text": "dinucleotide repeat polymorphism in GAD65"}, {"pubmed": 12606513, "text": "results support the hypothesis that presentation of GAD autoantigen by islet endothelium in vivo could promote transmigration of circulating islet autoantigen-specific T-cells primed in regional lymph nodes against islet autoantigens"}, {"pubmed": 14557453, "text": "GAD antibodies in type I diabetes mellitus has unique N-terminal linear epitopes that are located on the anchoring domain of GAD65 molecules."}, {"pubmed": 14576464, "text": "Data suggest that the conversion of full-length glutamate decarboxylase (GAD) to truncated GAD65 mediated by endogenous protease may represent an important mechanism in the regulation of GABA biosynthesis in the brain."}, {"pubmed": 14691540, "text": "GAD2 is mapped to chromosome 10p12 and is a candidate gene for human obesity"}, {"pubmed": 14691540, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15091314, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15091314, "text": "The StyI polymorphism in intron 11 of GAD2 did not associate with schizophrenia or suicidal ideation/behavior."}, {"pubmed": 15114630, "text": "Expression of GAD65 and GAD67 mRNA in the (dorsolateral prefrontal cortex) DLPFC and in the occipital cortex was significantly elevated in patients with schizophrenia, whereas the expression of the corresponding proteins and GAT-1 mRNA was unchanged."}, {"pubmed": 15147202, "text": "Results describe the effect of phosphorylation on the two well-defined glutamic acid decarboxylase (GAD) isoforms, namely, GAD65 and GAD67, using highly purified preparations of recombinant human brain GAD65 and GAD67."}, {"pubmed": 15163889, "text": "highly heterogeneous recognition of a multitude of INS and GAD65 peptide determinants occurred in the absence of protein recognition, and low functional avidity of the memory T cells"}, {"pubmed": 15170642, "text": "Among the type 1 diabetes children, increasing neutralising titres was associated positively with increasing antibody levels against GAD65. All siblings with antibodies against GAD 65 had significant titre increase against any of the CBV strains."}, {"pubmed": 15277377, "text": "specificity and avidity of GAD65 reactive T-cell clones isolated from patients with type 1 diabetes"}, {"pubmed": 15365614, "text": "Conformation-dependent autoantibodies directed against GAD65 are markers of Type 1 diabetes."}, {"pubmed": 15642443, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15671113, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15834701, "text": "GAD65 autoantibody response in the preclinical stage of type 1 diabetes is dynamic and related to the HLA genotypes that confer risk of diabetes."}, {"pubmed": 15836621, "text": "Site-directed mutagenesis study validates that cysteine-446 (present in GAD65 as a free sulfhydryl group) plays an important role in GAD65 activity."}, {"pubmed": 16122350, "text": "Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16385451, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16718280, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16718280, "text": "Out of 14 GAD2 markers screened in stage 1, only one met the threshold criteria for follow-up in a range of anxiety disorders and major depression"}, {"pubmed": 16731858, "text": "marginally significant (0.01 < P < 0.05) associations between four common variants of GAD2 and BMI were observed"}, {"pubmed": 16741266, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17034009, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17034009, "text": "The functional promoter GAD2 -243 A > G variant may influence risk for alcohol dependence (AD) in some populations, or its role may be limited to susceptibility to severe AD."}, {"pubmed": 17090641, "text": "DPD-defined epitope specificity is correlated directly with preserved beta-cell functional reserve in GAD65Ab-positive patients and is associated with the milder clinical phenotype of A+B+ KPDM"}, {"pubmed": 17167787, "text": "We found glutamic acid decarboxylase (Gad65)antibodies in idiopathic generalized epilepsy and type 1 diabetes."}, {"pubmed": 17384644, "text": "The structure of GAD67 shows a tethered loop covering the active site, providing a catalytic environment that sustains GABA production. In contrast, the same catalytic loop is inherently mobile in GAD65."}, {"pubmed": 17412563, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 17412563, "text": "study suggests that the GABRB2 and GAD1 genes individually, as well as the combined effects of the polymorphism in the GAD1, GAD2 and GABRB2 genes, are associated with schizophrenia in the Chinese population"}, {"pubmed": 17459095, "text": "GAD2-243A-->G polymorphism in a population of middle-aged White people associates with a modest reduction in body mass index and fasting and oral glucose tolerance test -related plasma glucose levels"}, {"pubmed": 17459095, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17479437, "text": "Glutamate cysteine ligase catalytic suunit promoter polymorphisms may influence GAD65 autoantibody levels and influence the age of onset of type 1 diabetes."}, {"pubmed": 17657474, "text": "Autoantibodies persist for 6 yearts after diagnosis of latent autoimmune diabetes in adultsbut levels and reactivity to different GAD65 epitopes are not associated with disease progression."}, {"pubmed": 17992632, "text": "Differences in the epitope GAD65 binding between mother and child at birth are limited. The epitope pattern at type 1 diabetes diagnosis differed from that at birth, supporting the view that disease-associated epitopes develop between birth and diagnosis."}, {"pubmed": 18047830, "text": "This study validates LIPS as a robust method to interrogate autoantibodies for the diagnosis of SPS and potentially other neurological diseases."}, {"pubmed": 18184926, "text": "The proximity of B- and T-cell epitopes within the GAD65 structure suggests that antigen-antibody complexes may influence antigen processing by accessory cells and thereby T-cell reactivity."}, {"pubmed": 18367670, "text": "conclude that masked GAD65Ab are present in the healthy population and that a lack of particular anti-Ids, rather than GAD65Ab per se, is a characteristic of type 1 diabetes."}, {"pubmed": 18371956, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18371956, "text": "SNP in the GAD2 gene was associated with increased BMI in late childhood and adolescence in this population of girls from western Pennsylvania."}, {"pubmed": 18378887, "text": "We describe using intermittent prednisolone and finding autoantibodies to GAD65 in juvenile neuronal ceroid lipofuscinosis."}, {"pubmed": 18487477, "text": "Patients with latent autoimmune diabetes in adults high GAD65(Ab) antibody titers resemble type 1 diabetic patients in their GAD65Ab epitope specificity."}, {"pubmed": 19058789, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19086053, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19111404, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19125103, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 19125103, "text": "These results suggest that GAD2 and GLUL do not play a major role in schizophrenia pathogenesis and there is no gene-gene interaction between the eight genes in the Japanese population."}, {"pubmed": 19156168, "text": "Clinical trial of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19229853, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19229853, "text": "behavioral inhibition-associated SNPs appear to be associated with differences in MYO3A- but not GAD2 lymphoblastoid-mRNA expression levels"}, {"pubmed": 19686769, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19686769, "text": "The results of this study suggested a role for the GAD2 gene in determining food intake, eating behaviors and weight gain over time in women."}, {"pubmed": 19783309, "text": "The structural features that distinguish GAD65 from GAD67 as a B cell autoantigen are related to functional requirements for its enzymatic mechanism."}, {"pubmed": 19874574, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19876004, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20010500, "text": "The number of human pancreatic islet cells expressing CGRP, GABA and GAD decreased significantly after the onset of Type 2 diabetes"}, {"pubmed": 20016201, "text": "The GAD 65 antigen could be identified in 8 patient sera: 4 children with diabetes mellitus type 1 and 4 adults initially taken as controls but who retrospectively showed signs of autoimmunity."}, {"pubmed": 20083660, "text": "Peptides in rotavirus VP7, similar to T cell epitopes in IA2 and GAD65, bind strongly to HLA-DRB1*04 molecules that confer susceptibility to type 1 diabetes and are also T cell epitopes in humans at risk for type 1 diabetes."}, {"pubmed": 20201926, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20379614, "text": "Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20468064, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20602615, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20634891, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20659789, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21073664, "text": "Studies indicate that T1DM can be detected by determining four autoantibodies, namely those antibodies against insulin, glutamic acid decarboxylase 65, insulinoma antigen (IA)-2 (ICA512) and the zinc transporter ZnT8."}, {"pubmed": 21250934, "text": "Alterations of glutamic acid decarboxylase (GAD) play a crucial role in schizophrenic pathology.  Read More: http://informahealthcare.com/doi/full/10.3109/15622975.2010.539270"}, {"pubmed": 21385406, "text": "Data suggest that regulation of ROS-GADAbs could offer novel tools for analysing and possibly treating T1D complications."}, {"pubmed": 21491431, "text": "Results describe the gross distribution patterns of GAD65 in human and rhesus monkey thalami and show that they are nearly identical."}, {"pubmed": 21494613, "text": "GAD65 is the major autoantigen in type 1 diabetes, and GAD67 per se has very low immunogenicity."}, {"pubmed": 21517929, "text": "the IgG subclass profile of anti-GAD65 Ab in healthy individuals differs from that in Type 1 Diabetes Patients."}, {"pubmed": 21792090, "text": "ZnT8A, GADA and IA-2A are autoantibodies that may have a role in successful pancreas graft survival"}, {"pubmed": 21937910, "text": "From midgestation to infancy, the pattern of GABAA receptor binding changed from uniformly low across all cortical layers to high levels concentrated in the middle laminae;GAD65 levels differentially increased."}, {"pubmed": 22103299, "text": "GAD65 palmitoylation is important for the delivery of GAD65 to inhibitory synapses and suggest that impairment of GAD65 palmitoylation by mhtt may lead to altered inhibitory neurotransmission in Huntington's disease."}, {"pubmed": 22104260, "text": "The presence of GADA post partum was positively associated with diabetes post partum (p=0.0009), but not with impaired glucose tolerance"}, {"pubmed": 22366823, "text": "The study demonstrated a statistically significant difference in the frequency of the GAD2 (+83987 T/A) genes between obese patients and controls in Taiwanese subjects."}, {"pubmed": 22552777, "text": "PHOX2B, FGF12 and GAD2 genes are hypermethylated in colorectal neoplastic tissue"}, {"pubmed": 22624794, "text": "Decreased expression of GAD65 protein within inhibitory boutons could contribute to auditory impairments in schizophrenia."}, {"pubmed": 22865904, "text": "In latent autoimmune diabetic subjects, high GAD antibody titer was associated with a profile of more severe autoimmunity and, in male gender, specifically predisposed to thyroid autoimmunity."}, {"pubmed": 23114513, "text": "GAD65 is severely reduced in Alzheimer's disease middle temporal gyrus, hippocampus and putamen neuropil granules."}, {"pubmed": 23822856, "text": "GAD65 expression in 313 gastric cancer tissues was significantly higher than in 60 adjacent non-tumour tissues. Moreover, the expression level of GAD65 significantly correlated with the depth of tumour invasion and TNM stage."}, {"pubmed": 24571444, "text": "GAD2 SNPs significantly associate with early-onset obsessive compulsive disorder."}, {"pubmed": 24661757, "text": "There is a marked gender dimorphism in GAD65 positivity, higher in obstructive sleep apnoea syndrome females vs. males."}, {"pubmed": 24874321, "text": "The decreased amount of GAD65 and GAD67 suggests the decreased synthesis of neurotransmitter and basic GABA pools that indicates insufficient functioning of the GABA system in the cerebellar cortex of Alzheimer's disease patients."}, {"pubmed": 24950944, "text": "Phosphate-activated glutaminase and GAD65/67 concentrations are compared in Alzheimer's disease cerebellum versus normal cerebellum controls"}, {"pubmed": 24993056, "text": "Cohort study shows that mean GAD65 mRNA levels in the prefrontal cortex area 9 are not altered in subjects with schizophrenia but are lower in subjects with schizoaffective disorder"}, {"pubmed": 25345799, "text": "Data suggest that women with gestational diabetes who develop autoantibodies against GAD2 (glutamate decarboxylase 2) exhibit higher blood glucose levels, insulin resistance, and impaired insulin secretion from beta cells in the postpartum period."}, {"pubmed": 25523979, "text": "GAD autoantibodies were associated with risk of developing type 1 diabetes."}, {"pubmed": 25645784, "text": "Kaplan-Meier survival curves estimated a worst pancreas graft survival for patients with positive IA-2 antibodies versus those patients with negative auto-antibodies and GAD65+ auto-antibodies after simultaneous pancreas kidney transplantation."}, {"pubmed": 25816051, "text": "Plasma GAD65 qualifies as a marker for early beta-cell loss after intraportal transplantation."}, {"pubmed": 25966064, "text": "we investigated the relationship between serum glutamic acid decarboxylase (GAD) autoantibody (Ab) levels and single nucleotide polymorphisms (SNPs) of the glutamic acid de-carboxylase 2 (GAD2) 5'-untranslated region"}, {"pubmed": 26362234, "text": "UV exposed hydrogen peroxide produces hydroxyl radical that may cause protein damage (GAD-65) to the extent of generating neo-epitopes on the molecule, making it immunogenic."}, {"pubmed": 27284108, "text": "Study propose that aberrant accumulation of immunogenic GAD65 in Golgi membranes facilitates inappropriate presentation to the immune system after release from stressed and/or damaged beta-cells, triggering autoimmunity."}, {"pubmed": 27967329, "text": "Genetic variability in GAD2 and GAD1 contributes to risk of methamphetamine dependence in the Thai population."}, {"pubmed": 28608287, "text": "This study showed a significant 58% increase of SCN GAD65/67-ir and a significant 169% increase of SCN GAD67-mRNA in the depression group."}, {"pubmed": 29236750, "text": "healthy donor NK cells showed similar degranulation against both GAD65 AA 114-122 pulsed and unpulsed APCs. The pathogenetic significance of the CD3-CD8dullCD56+ 'memory-like NK cell subset' with increased response upon secondary challenge in diabetics remains to be elucidated"}, {"pubmed": 29619531, "text": "In individuals with adult-onset diabetes, presence of N-terminally truncated GAD65 autoantibodies is associated with the clinical phenotype of autoimmune type 1 diabetes and predicts insulin therapy."}, {"pubmed": 29724796, "text": "we show an interaction of the genetic variation rs2236418 in the GAD2 gene and sex on GABA/glutamate balance in the pregenual anterior cingulate cortex"}, {"pubmed": 30203041, "text": "Posttransplant blood GAD65 and miR-375 performed equally well in quantifying early graft destruction and predicting graft outcome after islet transplantation in patients with type 1 diabetes."}, {"pubmed": 30264481, "text": "This binding characteristic is probably attributable to reduced presentation of two conformational epitopes by the N-terminal truncated molecule. These findings support the notion of disease-specific GAD65Ab epitope specificities and emphasize the need to evaluate the applicability of novel assays for different medical conditions."}, {"pubmed": 30853448, "text": "GAD65 antibody positivity was associated with an increased risk of future Type 2 Diabetes Mellitus in adults--{REVIEW}"}, {"pubmed": 31866536, "text": "GAD1 but not GAD2 polymorphisms are associated with heroin addiction phenotypes."}, {"pubmed": 32456344, "text": "Neurological Syndromes Associated with Anti-GAD Antibodies."}, {"pubmed": 35196314, "text": "Similarities between bacterial GAD and human GAD65: Implications in gut mediated autoimmune type 1 diabetes."}, {"pubmed": 35420879, "text": "The plasma level of glutamic acid decarboxylase 65 (GAD65) increased in severely autistic Iranian children."}, {"pubmed": 36879107, "text": "Heterogeneity of circulating CXCR5-PD-1[hi]Tph cells in patients of type 2 and type 1 diabetes in Chinese population."}], "genomic_pos": {"chr": "10", "end": 26304558, "ensemblgene": "ENSG00000136750", "start": 26216665, "strand": 1}, "genomic_pos_hg19": {"chr": "10", "end": 26593487, "start": 26505236, "strand": 1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0006540", "qualifier": "involved_in", "term": "glutamate decarboxylation to succinate"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0007268", "pubmed": 8954991, "qualifier": "involved_in", "term": "chemical synaptic transmission"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0009410", "qualifier": "involved_in", "term": "response to xenobiotic stimulus"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0009449", "qualifier": "involved_in", "term": "gamma-aminobutyric acid biosynthetic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032570", "qualifier": "involved_in", "term": "response to progesterone"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0042220", "qualifier": "involved_in", "term": "response to cocaine"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0061771", "qualifier": "involved_in", "term": "response to caloric restriction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0071456", "qualifier": "involved_in", "term": "cellular response to hypoxia"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1990416", "qualifier": "involved_in", "term": "cellular response to brain-derived neurotrophic factor stimulus"}], "CC": [{"evidence": "IEA", "gocategory": "CC", "id": "GO:0000139", "qualifier": "located_in", "term": "Golgi membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005737", "qualifier": "is_active_in", "term": "cytoplasm"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0030424", "qualifier": "located_in", "term": "axon"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0030672", "qualifier": "located_in", "term": "synaptic vesicle membrane"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0042734", "qualifier": "located_in", "term": "presynaptic membrane"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0043025", "qualifier": "located_in", "term": "neuronal cell body"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0048471", "qualifier": "located_in", "term": "perinuclear region of cytoplasm"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0060077", "qualifier": "located_in", "term": "inhibitory synapse"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0061202", "qualifier": "located_in", "term": "clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0098982", "qualifier": "located_in", "term": "GABA-ergic synapse"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0004351", "qualifier": "enables", "term": "glutamate decarboxylase activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [10671565, 25416956, 32296183], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0016595", "qualifier": "enables", "term": "glutamate binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0030170", "qualifier": "enables", "term": "pyridoxal phosphate binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0044877", "qualifier": "enables", "term": "protein-containing complex binding"}]}, "homologene": {"genes": [[7955, 550403], [8364, 100493806], [9031, 395395], [9544, 613029], [9598, 466026], [9606, 2572], [9615, 487107], [9913, 512459], [10090, 14417], [10116, 24380]], "id": 20223}, "interpro": [{"desc": "Pyridoxal phosphate-dependent decarboxylase", "id": "IPR002129", "short_desc": "PyrdxlP-dep_de-COase"}, {"desc": "Pyridoxal phosphate-dependent transferase, major domain", "id": "IPR015421", "short_desc": "PyrdxlP-dep_Trfase_major"}, {"desc": "Pyridoxal phosphate-dependent transferase", "id": "IPR015424", "short_desc": "PyrdxlP-dep_Trfase"}, {"desc": "Pyridoxal-phosphate binding site", "id": "IPR021115", "short_desc": "Pyridoxal-P_BS"}], "ipi": ["IPI00012796", "IPI00444513", "IPI00641751"], "map_location": "10p12.1", "name": "glutamate decarboxylase 2", "other_names": ["65 kDa glutamic acid decarboxylase", "GAD-65", "Glutamate decarboxylase-2 (pancreas)", "glutamate decarboxylase 2", "glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)"], "pantherdb": {"HGNC": "4093", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "95634", "ortholog_type": "LDO", "panther_family": "PTHR45677", "taxid": 10090, "uniprot_kb": "P48320"}, {"RGD": "2653", "ortholog_type": "LDO", "panther_family": "PTHR45677", "taxid": 10116, "uniprot_kb": "Q05683"}, {"Ensembl": "ENSGALG00000040436", "ortholog_type": "LDO", "panther_family": "PTHR45677", "taxid": 9031, "uniprot_kb": "A0A1D5PPX6"}, {"ZFIN": "ZDB-GENE-030909-9", "ortholog_type": "LDO", "panther_family": "PTHR45677", "taxid": 7955, "uniprot_kb": "F1R9E8"}, {"WormBase": "WBGene00006762", "ortholog_type": "O", "panther_family": "PTHR45677", "taxid": 6239, "uniprot_kb": "G5EDB7"}, {"FlyBase": "FBgn0004516", "ortholog_type": "O", "panther_family": "PTHR45677", "taxid": 7227, "uniprot_kb": "P20228"}], "uniprot_kb": "Q05329"}, "pathway": {"humancyc": [{"id": "GLUDEG-I-PWY", "name": "GABA shunt"}, {"id": "PWY0-1305", "name": "glutamate dependent acid resistance"}], "kegg": [{"id": "hsa00250", "name": "Alanine, aspartate and glutamate metabolism - Homo sapiens (human)"}, {"id": "hsa00410", "name": "beta-Alanine metabolism - Homo sapiens (human)"}, {"id": "hsa00430", "name": "Taurine and hypotaurine metabolism - Homo sapiens (human)"}, {"id": "hsa00650", "name": "Butanoate metabolism - Homo sapiens (human)"}, {"id": "hsa04727", "name": "GABAergic synapse - Homo sapiens (human)"}, {"id": "hsa04940", "name": "Type I diabetes mellitus - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-112310", "name": "Neurotransmitter release cycle"}, {"id": "R-HSA-112315", "name": "Transmission across Chemical Synapses"}, {"id": "R-HSA-112316", "name": "Neuronal System"}, {"id": "R-HSA-212436", "name": "Generic Transcription Pathway"}, {"id": "R-HSA-73857", "name": "RNA Polymerase II Transcription"}, {"id": "R-HSA-74160", "name": "Gene expression (Transcription)"}, {"id": "R-HSA-888568", "name": "GABA synthesis"}, {"id": "R-HSA-888590", "name": "GABA synthesis, release, reuptake and degradation"}, {"id": "R-HSA-8986944", "name": "Transcriptional Regulation by MECP2"}, {"id": "R-HSA-9022927", "name": "MECP2 regulates transcription of genes involved in GABA signaling"}], "wikipathways": [{"id": "WP106", "name": "Alanine and aspartate metabolism"}, {"id": "WP3940", "name": "One-carbon metabolism and related pathways"}, {"id": "WP550", "name": "Biogenic Amine Synthesis"}]}, "pdb": ["1ES0", "2OKK"], "pfam": "PF00282", "pharmgkb": "PA28508", "pharos": {"target_id": 10542, "tdl": "Tbio"}, "pir": "A41935", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF249759", "relationship": "is"}, {"id": "GNF249760", "relationship": "is"}, {"id": "GNF249761", "relationship": "is"}, {"id": "GNF249762", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF083154", "relationship": "is"}, {"id": "GNF083155", "relationship": "is"}, {"id": "GNF083156", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF054487", "relationship": "is"}, {"id": "GNF059264", "relationship": "is"}, {"id": "GNF074631", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF066289", "relationship": "is"}, {"id": "GNF066290", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF095010", "relationship": "is"}, {"id": "GNF134667", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000010.11", "NC_060934.1"], "protein": ["NP_000809.1", "NP_001127838.1"], "rna": ["NM_000818.3", "NM_001134366.2"], "translation": [{"protein": "NP_000809.1", "rna": "NM_000818.3"}, {"protein": "NP_001127838.1", "rna": "NM_001134366.2"}]}, "reporter": {"HG-U133_Plus_2": ["1568601_at", "206780_at", "211264_at", "216651_s_at", "243265_at"], "HG-U95Av2": ["32279_at", "32280_at"], "HTA-2_0": "TC10000180.hg.1", "HuEx-1_0": ["3239667", "3239735"], "HuGene-1_1": "7926766", "HuGene-2_1": "16703382"}, "summary": "This gene encodes one of several forms of glutamic acid decarboxylase, identified as a major autoantigen in insulin-dependent diabetes. The enzyme encoded is responsible for catalyzing the production of gamma-aminobutyric acid from L-glutamic acid. A pathogenic role for this enzyme has been identified in the human pancreas since it has been identified as an autoantibody and an autoreactive T cell target in insulin-dependent diabetes. This gene may also play a role in the stiff man syndrome. Alternative splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Oct 2008].", "symbol": "GAD2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1414926"}, "unigene": "Hs.231829", "uniprot": {"Swiss-Prot": "Q05329", "TrEMBL": ["Q5VZ31", "Q5VZ30", "A0A3B3IU09"]}, "wikipedia": {"url_stub": "GAD2"}}